April 23, 2025
Joint grant program will provide researchers focused on emerging areas of oncology with powerful multi-omic platforms to drive new discoveries DURHAM, N.C. & FREMONT, Calif. -- BioSkryb Genomics, a pioneer in single-cell and ultra–low-input multi-omic solutions, and Ultima Genomics, a leader in scalable and cost-effective sequencing, today announced a collaboration designed to accelerate next-generation oncology research. [...]
Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board
April 23, 2025
RICHMOND, Va. -- Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova’s board, and the successful completion of a new round of growth equity capital. These developments support Grenova’s strategic vision to drive innovation, expand automation capabilities, and deliver transformative [...]
Sensitive and specific DUB enzyme assay kits
April 23, 2025
Amsbio has launched a new range of Deubiquitinating (DUB) enzyme assay kits supplied in a convenient and easy-to-use 96-well assay format. With minimal setup required and no need for substrate preparation, these ready-to-use kits accelerate routine DUB activity assays without compromising data quality. Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in [...]
Beckman Coulter Life Sciences Transforms Purification with the Launch of the OptiMATE Gradient Maker
April 23, 2025
Automated Density Gradient Preparation Reduces Run Times by up to 75% INDIANAPOLIS – Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of the OptiMATE Gradient Maker, a groundbreaking instrument designed to automate the process of density gradient ultracentrifugation (DGUC). The new system accelerates purification processes [...]
April 23, 2025
Announces majority investment in NGS bioinformatics solution provider Ridom GmbH New NGS microbiology solutions for hygiene testing and epidemiological studies HAI (Hospital-Acquired Infections) tracing with rapid, cost-effective IR Biotyper® testing, followed by selective NGS reflex testing for confirmation and phylogeny Unique workflow with MALDI Biotyper®-based microbial species identification followed by selective NGS-based strain determination and [...]
April 23, 2025
Today, Nikon Instruments Inc. announced the opening of its newest Nikon Center of Excellence imaging facility at the University of Arizona Cancer Center in Tucson, Arizona. This new Center will bring state-of-the-art imaging capabilities to the University of Arizona Cancer Center, establishing it as one of the most advanced bioscience imaging facilities in the Western United States. [...]
bioMérieux Launches WatchFire PCR Test to Detect Respiratory Pathogens in Wastewater
April 23, 2025
bioMérieux has launched the WatchFire molecular testing solution, a PCR test to detect viruses and bacteria in wastewater and respond to potential infectious disease outbreaks, according to the company. RT’s Three Key Takeaways Product Launch: bioMérieux has introduced the WatchFire molecular testing solution, a 22-target PCR test running on the Biofire FilmArray Torch, designed to detect [...]
Scientific Industries Secures Funding
April 22, 2025
BOHEMIA, N.Y. — Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today that it has successfully secured approximately $1.6 million in a private placement to advance the Company’s SBI’s DOTS Platform, a real-time bioprocessing system and for general corporate use. The offering consisted of 1,550,000 shares [...]
April 22, 2025
The EYRA protein analysis platform will significantly reduce costs and hassle associated with other solutions, aiding researchers all over the world within immunology, infectious diseases and inflammation. Stockholm, Sweden: Mabtech, a Swedish life science tools company developing immunoassay biochemical tests for research, announces a new highly innovative image-based multiplex platform in close collaboration with research [...]
April 22, 2025
ChromaGenix will combine industry expertise, academic innovation, and $35 million in planned investment to develop and scale next-generation purification technologies for gene therapies, vaccines, and immunotherapies. LigaTrap Technologies (now ChromaGenix) is an innovative North Carolina biotechnology company offering proprietary purification technologies for production of antibody-based medications, viral vaccines, and gene therapies. We're pleased to announce [...]

